| 6CCY: reference: Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT., Parthasarathy S, Henry K, Pei H, Clayton J, Rempala M, Johns D, De Frutos O, Garcia P, Mateos C, Pleite S, Wang Y, Stout S, Condon B, Ashok S, Lu Z, Ehlhardt W, Raub T, Lai M, Geeganage S, Burkholder TP, Bioorg Med Chem Lett. 2018 Apr 2. pii: S0960-894X(18)30297-X. doi:, 10.1016/j.bmcl.2018.03.092. PMID: 29655979 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).